iPS Academia Japan

NEW YORK (GenomeWeb News) – Life Technologies today announced a worldwide, non-exclusive deal with iPS Academia Japan for its induced pluripotent stem cell patent portfolio.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Cellular Dynamics today announced it has expanded its distribution deal with iPS Academia Japan to include iCell Neurons and iCell Endothelial Cells.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Sigma-Aldrich today said that it has licensed worldwide rights to Kyoto University's induced pluripotent stem cell patent portfolio.

iPS Academia Japan will distribute the firm's iCell Cardiomyocytes in Japan.

The French firm licensed non-exclusive rights to certain patents covering research conducted by Shinya Yamanaka of the Center for iPS Cell Research and Application at Kyoto University in Japan.

Cellular Dynamics and iPS Academia Japan announced a non-exclusive licensing agreement giving CDI access to an induced pluripotent stem cell portfolio based on research done by Kyoto University researcher Shinya Yamanaka.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.